LACINDA FOLEY: Open Payments
NPI 1508511924 · BASSETT, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $42 |
| Alkermes, Inc. | 2 | $34 |
| Dexcom, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: UBRELVY, Dexcom G6 Transmitter, ARISTADA, XIFAXAN, VIVITROL, AIRSUPRA, VRAYLAR.
Industry payments across VA — which companies pay providers there.
